🇺🇸United States

DEA Fines for Controlled Substance Dispensing Violations

1 verified sources

Definition

Veterinary practices incur fines for failing to comply with DEA labeling, recordkeeping, VCPR, and dispensing requirements for controlled substances. Non-compliance with federal and state regulations leads to regulatory penalties per infraction. These violations are systemic due to complex rules across schedules and jurisdictions.

Key Findings

  • Financial Impact: $15,040 per infraction
  • Frequency: Per audit or violation occurrence - recurring in non-compliant practices
  • Root Cause: Inadequate training on DEA labeling, recordkeeping, VCPR requirements, and state variations

Why This Matters

This pain point represents a significant opportunity for B2B solutions targeting Veterinary Services.

Affected Stakeholders

Veterinarians, Practice Managers, Veterinary Technicians

Deep Analysis (Premium)

Financial Impact

$15,040 per violation; 1-2 violations annually = $15,040-$30,080 annual exposure • $15,040 per violation; 2-3 violations annually = $30,080-$45,120 annual exposure • $15,040 per violation; 2-4 violations annually = $30,080-$60,160 annual exposure

Unlock to reveal

Current Workarounds

Disconnected Excel files, email chains, manual inventory counts, WhatsApp messages between veterinary staff and admin, inconsistent formatting across records • Equine field clinic notes mixed with controlled substance logs, verbal communication between barn staff and lab technician, no centralized VCPR (Veterinarian-Client-Patient-Relationship) documentation, Excel tracking by horse ID • Excel spreadsheet with manual notes, handwritten DEA log books, verbal confirmation of VCPR, post-it reminders on bottles

Unlock to reveal

Get Solutions for This Problem

Full report with actionable solutions

$99$39
  • Solutions for this specific pain
  • Solutions for all 15 industry pains
  • Where to find first clients
  • Pricing & launch costs
Get Solutions Report

Methodology & Sources

Data collected via OSINT from regulatory filings, industry audits, and verified case studies.

Evidence Sources:

Related Business Risks

Request Deep Analysis

🇺🇸 Be first to access this market's intelligence